Control Flo Medical has signed an agreement with Israel-based Degania Silicone for the design & manufacturing of the patented ResQ urological catheter system.
ResQ is a patented disruptive technology for existing and intermittent catheter users. The urinary blockage and drainage catheter secured two patents, which are owned by Control Flo Medical.
Control Flo Medical COO Philip White said: “We are pleased to partner with a globally recognized leader in medical device manufacturing, Degania Silicone, a company with significant catheter expertise in all-development phases, including a design and manufacturing team that provides customer-support around the globe.”
Degania North America sales and marketing vice president Louis Weijers said: “We are very excited about working together with the Control Flo Medical team to reach commercialization regarding Control Flo Medical’s ResQ catheters.”
Degania Silicone provides indwelling medical catheters, silicone medical products and medical devices for critical care and operating rooms, as well as direct-to-customer products.
The company operates modern production facilities in France, India, Slovakia and Israel.
Control Flo Medical is engaged in the development of novel product solutions for the treatment of urinary incontinence.